2023 ARCHIVES

See you in 2024!

Missed Discovery On Target This Year?

Missed this year's event? Access content across all of this year's programs On-Demand. At your convenience, access archived presentations for On-Demand learning from anywhere, at any time.

This past September 25-28, 2023, over 1,100 international attendees (90% in-person) learned and networked together at our 20th Anniversary Discovery on Target.

The sold-out Exhibit Hall featured 93 companies with novel solutions and technologies. These leading providers extended their impact across agenda presentations highlighting new offerings to the scientific community. Attendees also enjoyed 100+ posters by students, academia, and industry revealing drug discovery research on the cutting edge.

The event included 275+ expert speakers, 16 conference tracks, 2 symposia, 8 interactive courses, and 1 in-depth training seminar. Interest and track hopping were healthy across topics, from popular kinases and immunomodulation to protein degradation and AI; new or expanded programming on transcription factors and small molecules for cancer targets; stalwarts like antibodies; and plenty more.

For a review of fragment-based drug discovery talks written by
Dr. Daniel A. Erlanson of Frontier Medicines, click here for his Practical Fragments blogpost:
https://practicalfragments.blogspot.com/2023/10/discovery-on-target-2023.html

Thank you for contributing to the life science and lifeblood of Discovery on Target, via your diverse perspectives and targets. Feel free to share ideas and topics with me and submit a speaker proposal for 2024. Our team looks forward to welcoming you back to Boston for our 22nd Annual event this
September 30 - October 3, 2024. See you next fall!

Best,
An-Dinh Nguyen
Team Lead, Discovery on Target
anguyen@healthtech.com

Read attendee, sponsor and speaker testimonials here!

2023 Conference Programs
> VIEW EVENT AT-A-GLANCE

September 26-27

September 27-28

September 25:
Emerging Immune Modulation Strategies Symposium

September 25:
Strategies for Targeting Kinases Symposium

Short Courses

Join Us in Boston for Discovery On Target 2023!

Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules.

We aim to meet your research needs. Visit numerous concurrent sessions for informative presentations, lively dialogue, and meaningful connections with peers. Customize your experience further through focused short courses and a training seminar, interactive group discussions, and networking options that help you engage with experts and solutions providers.

Our 20th Anniversary event brings back popular topics like immunomodulation, protein degraders, and RNA, plus new, expanded, or returning programming on transcription factors, small molecules for cancer targets, and kinases.

HOTEL & TRAVEL

WAYS TO PARTICIPATE

1,100+

Attendees

275

Presentations

100+

Research Posters

Conference Tracks

Symposia

Training Seminar

In-Person Short Courses

Exhibitors

Countries Represented

As of 9/18/23

2023 Premier Sponsors

View All Sponsors

2023 Plenary Keynote Program

The New Science of Therapeutics
Jay E. Bradner, MD, Physician Scientist, Former President, Novartis Institutes for BioMedical Research, Inc.

Accelerating Drug Discovery Using Machine Learning and Cell Painting Images
Anne E. Carpenter, PhD, Senior Director, Imaging Platform & Institute Scientist, Broad Institute

Shantanu Singh, PhD, Senior Group Leader, Machine Learning, Imaging Platform, Broad Institute

Flexible Registration – Seamlessly switch between In-Person and/or Virtual

Select an in-person or virtual option, and you have the flexibility to switch your preferred event experience at any time leading up to the conference. Our flexible registration is designed to take the uncertainties out of these uncertain times.

2023 Conference Programs
> VIEW EVENT AT-A-GLANCE

Protein Degraders and Molecular Glues – Part 1

Proteomics-Driven Drug Discovery

Small Molecules Targeting RNA

Small Molecules for Cancer Targets – Part 1

Neurodegeneration Targets

GPCR-Based Drug Discovery

Antibodies Against Membrane Protein Targets – Part 1

AI/ML-Enabled Drug Discovery – Part 1

Protein Degraders and Molecular Glues – Part 2

Genomics-Driven Drug Discovery

Targeting Transcription FactorsNEW

Small Molecules for Cancer Targets – Part 2NEW

Fibrosis and Inflammation

Lead Generation Strategies

Antibodies Against Membrane Protein Targets – Part 2

AI/ML-Enabled Drug Discovery – Part 2

2023 Conference Programs > VIEW EVENT AT-A-GLANCE

2023 Conference Programs
> VIEW EVENT AT-A-GLANCE